We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

News   Nov 01, 2017 | Original Story from American Society for Biochemistry and Molecular Biology.

 
How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

A new project reveals that the enzyme GSK-3, a target of the mood disorder drug lithium, has a role in controlling alternative splicing in cells. This observation may yield insights into leukemia. Credit: Mansi Shinde and Simone Sidoli.

 
 
 

RELATED ARTICLES

Forensic Ice Detectives Piece Together Startling Picture

News

Using remote sensing technology, scientists have been investigating the dramatic acceleration in loss of the Russian ice cap,which changed from 2 inches to 82 feet per day.

READ MORE

Death and Decomposition Keeps the World Going

News

Scientists now have a better way to investigate how decomposing plants’ and animals’ contribute to the ecosystem.

READ MORE

Fat Holds the Key

News

Scientists have discovered molecules of fat in an ancient fossil to reveal the earliest confirmed animal in the geological record that lived on Earth 558 million years ago.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE